The Journal of Phytopharmacology, 2021;10(5):323-330 ; DOI:10.31254/phyto.2021.10508
Pistacia integerrima (Shringi)- A Plant with Significant Pharmacological Activities
1. Shuddhi Ayurveda, Jeena Sikho Lifecare Pvt. Ltd. Chandigarh, India
*Author to whom correspondence should be addressed.
Received: 26th July, 2021 / Accepted: 17th August, 2021
Pistacia integerrima is an important medicinal plant belongs to the family Anacardiacea. It is commonly called as Crab’s claw in English and Shani/Shringi in Hindi. It is a single-stemmed, dioecious tree widely distributed in countries like Nepal, China, Afghanistan, Pakistan, Armenia, North-west and West Himalayas. The plant has significant applications in the traditional systems of medications such as Ayurveda, Unani and Siddha. In addition, the plant is also used in many folkloric cultures around the world to treat a vast array of human ailments such as diarrhoea, dysentery, fever, vomiting, skin diseases, respiratory ailments and psoriasis appetizer, hepatitis and liver related disorders. The characteristic feature of the plant is its essential oil content comprised of many important phytochemical constituents such as alpha-pinene, camphene, di-limonene, 1:8-cineol, caprylic acid, alpha-terpineol and aromadendrene. However, the plant contains many other important secondary metabolites such as steroids, flavonoids, tannins, saponins and phenols which are associated with important pharmacological activities such as anti-bacterial, anti-oxidant, anti-inflammatory, cardio-protective, anti-cancer, antidiarrhoeal, anticonvulsant and muscle relaxant. The aim of the present study is to summarize the recent pharmacological activities of Pistacia integerrima along with its utilization in traditional medication systems.
Shringi, Rasapanchak, Pistagremic acid, Anti-bacterial, Anti-oxidant.
HOW TO CITE THIS ARTICLE
Manish Grover. Pistacia integerrima (Shringi)- A Plant with Significant Pharmacological Activities. J Phytopharmacol 2021; 10(5):323-330. doi: 10.31254/phyto.2021.10508
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.